The Cancer Control and Population Health (CCPH) program is a relatively new program within the Kansas University Cancer Center, developed explicitly to identify better ways to bring cancer control efforts into high risk and underserved communities. The CCPH program is co-led by Edward F. Ellerbeck, MD, MPH and Kimberly K. Engelman, PhD and brings together an interdisciplinary team of researchers focused on 1) advancing the science of working with underserved communities in efforts to improve cancer control and reduce cancer-related health disparities;2) identifying new strategies to improve smoking cessation and enhance the delivery of effective smoking cessation services;and 3) developing and testing novel methods to improve the delivery and uptake of effective cancer screening services. Since the creation of the CCPH, program members have made remarkable progress in developing the infrastructure to conduct cancer control research in underserved, regional rural, American Indian, African American, and Latino communities. Paralleling this growth in infrastructure has been a rapid growth in cancer control funding and an increase in program membership. CCPH program activities support both intra- and inter-programmatic interactions through translational research seminars, a visiting scholars program, research symposia, and research interest groups. A strong mentoring program has helped junior faculty procure training grants and minority supplements. CCPH research efforts have led to new discoveries related to the treatment of African American light smokers and the integration of smoking cessation efforts into rural primary care. Applying community based participatory research methods, CCPH researchers developed the first culturally tailored smoking cessation program designed for a heterogeneous American Indian community. The community-based research in the CCPH is strongly supported by a vibrant rural practice-based research network, the American Indian Health Research and Education Alliance, and the Latino Health Initiatives Network. This support has allowed CCPH members to enroll more than 10,000 people from underserved communities into cancer control research studies over the past 5 years. The 23 members of the CCPH program come from 5 departments in 2 schools. Although many members are new to cancer control research, they represent a rich mix of expertise, including psychologists, sociologists, neuroscientists, primary care physicians, oncologists, epidemiologists, biostatisticians, anthropologists, economists, pharmacists, communication specialists, and health services researchers. Program members are supported by $11.5 million in total annual funds, including $3.6 million from the National Cancer Institute. CCPH members have published 131 articles since 2006 of which 53 (40%) were intra-programmatic and 38 (29%) were inter-programmatic. In addition, CCPH members have accounted for 52.23% of the usage of the Biostatistics &Informatics Shared Resource and 9.6% of the Biospecimen Shared Resource.
The Cancer Control and Population Health program is identifying better ways to engage high risk and underserved communities in cancer control efforts. Members of this program are focused on advancing implementation science related to cancer screening and developing better techniques to reduce tobacco consumption.
| Gonzalez-Mercado, Velda J; Fridley, Brooke L; Saligan, Leorey N (2018) Sestrin family of genes and their role in cancer-related fatigue. Support Care Cancer 26:2071-2074 |
| Rebbeck, Timothy R (see original citation for additional authors) (2018) Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations. Hum Mutat 39:593-620 |
| Roy, Anuradha (2018) Early Probe and Drug Discovery in Academia: A Minireview. High Throughput 7: |
| Lea, Wendy A; Parnell, Stephen C; Wallace, Darren P et al. (2018) Human-Specific Abnormal Alternative Splicing of Wild-Type PKD1 Induces Premature Termination of Polycystin-1. J Am Soc Nephrol 29:2482-2492 |
| Hirst, Jeff; Pathak, Harsh B; Hyter, Stephen et al. (2018) Licofelone Enhances the Efficacy of Paclitaxel in Ovarian Cancer by Reversing Drug Resistance and Tumor Stem-like Properties. Cancer Res 78:4370-4385 |
| Trinca, Gloria M; Goodman, Merit L; Papachristou, Evangelia K et al. (2018) O-GlcNAc-Dependent Regulation of Progesterone Receptor Function in Breast Cancer. Horm Cancer 9:12-21 |
| Subramaniam, Dharmalingam; Kaushik, Gaurav; Dandawate, Prasad et al. (2018) Targeting Cancer Stem Cells for Chemoprevention of Pancreatic Cancer. Curr Med Chem 25:2585-2594 |
| Beadnell, Thomas C; Scheid, Adam D; Vivian, Carolyn J et al. (2018) Roles of the mitochondrial genetics in cancer metastasis: not to be ignored any longer. Cancer Metastasis Rev : |
| Li, Linda Xiaoyan; Zhou, Julie Xia; Calvet, James P et al. (2018) Lysine methyltransferase SMYD2 promotes triple negative breast cancer progression. Cell Death Dis 9:326 |
| Peng, Weidan; Furuuchi, Narumi; Aslanukova, Ludmila et al. (2018) Elevated HuR in Pancreas Promotes a Pancreatitis-Like Inflammatory Microenvironment That Facilitates Tumor Development. Mol Cell Biol 38: |
Showing the most recent 10 out of 177 publications
